EORTC 1634-Brain Tumour Group trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I) receives support from Gateway for Cancer Research℠
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Belgium, North America, United States
Keywords: Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.